Vilas-Boas V - Search Results

1

Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.

Perri G, Vilas Boas VG, Nogueira MRS, Mello Júnior EJF, Coelho AL, Posadas EM, Hogaboam C, Cavassani KA, Campanelli AP. Perri G, et al. Among authors: vilas boas vg. Cancer Immunol Immunother. 2024 Apr 25;73(6):110. doi: 10.1007/s00262-024-03676-8. Cancer Immunol Immunother. 2024. PMID: 38662248 Free PMC article.

2

Differential impact of diesel exhaust particles on glutamatergic and dopaminergic neurons in Caenorhabditis elegans: A neurodegenerative perspective.

Chatterjee N, González-Durruthy M, Costa MD, Ribeiro AR, Vilas-Boas V, Vilasboas-Campos D, Maciel P, Alfaro-Moreno E. Chatterjee N, et al. Among authors: vilas boas v. Environ Int. 2024 Apr;186:108597. doi: 10.1016/j.envint.2024.108597. Epub 2024 Mar 22. Environ Int. 2024. PMID: 38579453 Free article.

3

Ultrasonography as an instrument to evaluate lymphedema secondary to breast cancer: systematic review.

de Rezende LF, Piloni JPM, Kempa VL, Silva JFR, Vilas Boas VF, Carvalho RL, Marx ÂG. de Rezende LF, et al. Among authors: vilas boas vf. J Vasc Bras. 2023 Dec 18;22:e20220144. doi: 10.1590/1677-5449.202201441. eCollection 2023. J Vasc Bras. 2023. PMID: 38162983 Free PMC article. Review.

4

Microfluidic-based skin-on-chip systems for safety assessment of nanomaterials.

Costa S, Vilas-Boas V, Lebre F, Granjeiro JM, Catarino CM, Moreira Teixeira L, Loskill P, Alfaro-Moreno E, Ribeiro AR. Costa S, et al. Among authors: vilas boas v. Trends Biotechnol. 2023 Oct;41(10):1282-1298. doi: 10.1016/j.tibtech.2023.05.009. Epub 2023 Jul 5. Trends Biotechnol. 2023. PMID: 37419838 Free article. Review.

5

Expression of connexins and pannexins in diseased human liver.

Leroy K, Vilas-Boas V, Gijbels E, Vanderborght B, Devisscher L, Cogliati B, Van Den Bossche B, Colle I, Vinken M. Leroy K, et al. Among authors: vilas boas v. EXCLI J. 2022 Aug 22;21:1111-1129. doi: 10.17179/excli2022-5163. eCollection 2022. EXCLI J. 2022. PMID: 36381643 Free PMC article.

6

Nanosafety: An Evolving Concept to Bring the Safest Possible Nanomaterials to Society and Environment.

Lebre F, Chatterjee N, Costa S, Fernández-de-Gortari E, Lopes C, Meneses J, Ortiz L, Ribeiro AR, Vilas-Boas V, Alfaro-Moreno E. Lebre F, et al. Among authors: vilas boas v. Nanomaterials (Basel). 2022 May 25;12(11):1810. doi: 10.3390/nano12111810. Nanomaterials (Basel). 2022. PMID: 35683670 Free PMC article. Review.

7

Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.

Arnesdotter E, Gijbels E, Dos Santos Rodrigues B, Vilas-Boas V, Vinken M. Arnesdotter E, et al. Among authors: vilas boas v. Methods Mol Biol. 2022;2425:521-535. doi: 10.1007/978-1-0716-1960-5_20. Methods Mol Biol. 2022. PMID: 35188645

8

Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals.

Vilas-Boas V, Gijbels E, Leroy K, Pieters A, Baze A, Parmentier C, Vinken M. Vilas-Boas V, et al. Int J Mol Sci. 2021 Oct 12;22(20):11005. doi: 10.3390/ijms222011005. Int J Mol Sci. 2021. PMID: 34681664 Free PMC article.

9

Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models.

Vilas-Boas V, Vinken M. Vilas-Boas V, et al. Arch Toxicol. 2021 Jan;95(1):27-52. doi: 10.1007/s00204-020-02940-x. Epub 2020 Nov 6. Arch Toxicol. 2021. PMID: 33155068 Review.

10

Magnetic Hyperthermia for Cancer Treatment: Main Parameters Affecting the Outcome of In Vitro and In Vivo Studies.

Vilas-Boas V, Carvalho F, Espiña B. Vilas-Boas V, et al. Molecules. 2020 Jun 22;25(12):2874. doi: 10.3390/molecules25122874. Molecules. 2020. PMID: 32580417 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page